OncoLinkTV: Breathing New Life into Lung Cancer Treatment

This article has been archived.
Please use for reference only.

Last Modified: August 12, 2003


Join OncoLink for Breathing New Life into Lung Cancer Treatment, Future Trends in Lung Cancer Treatment: New Therapeutic Approaches and the Role of Patient Advocacy Media Summit & Webcast which was held at the 10th World Congress on Lung Cancer (WCLC) in Vancouver, Canada, August 11, 2003.

According to the World Health Organisation (WHO) more than 6 million people worldwide die every year as a result of cancer, the second most prevalent cause of death in the developing world. Lung cancer is the most common cancer worldwide among men and women accounting for 1.1 million deaths each year, yet there are very few patient advocacy groups in the world specifically dedicated to this devastating disease. International experts will convene at the 10th World Conference on Lung Cancer (WCLC) in Vancouver, Canada, from 10-14 August to discuss new approaches in providing patients with more therapeutic options.

In order to view this webcast, you will need Windows Media Player and Microsoft Internet Explorer or Netscape Navigator 4.X. Please see our help page for further information.


Welcome and Introduction
Dr. Paul A. Bunn, Jr.

Cancers: The Therapeutic Landscape
Dr. Paul A. Bunn, Chairperson, Former-President ASCO, University of Colorado Cancer Center, USA

Achieving Optimal Care: The Role of Patient Advocacy
Lynne Robertson, Roy Castle Lung Foundation, UK

Gemzar® Combinations in Lung Cancer Care
Dr. Christian Manegold, Professor of Medicine, University of Heidelberg, Germany

Alimta: Achieving the Fullest Potential of a New Agent for Cancers of the Lung
Dr. Rafael Rosell, Scientific Director of Oncology Research, Institut Català d'Oncologia, Spain

Questions and Answers
Dr. Paul A. Bunn, Chair

Supported by an unrestricted educational grant from Eli Lilly and Company.